Addiction Provider Caron Names New COO, Opens New Research Center

Addiction-focused treatment provider Caron has named Kristine Bashore its next chief operating officer.

In this new role Bashore will be responsible for leading day-to-day operations and helping the company execute its three-year strategic plan. Bashore has been with Caron since 2000, previously serving as the company’s chief human resource officer, chief marketing officer and most recently the chief administrative officer. Before coming to Caron, Bashore served as a senior human resources manager at Covance.

As COO Bashore will be in charge of the provider’s facilities, human resources, training, quality, compliance, risk management, admissions, regional services, business development, marketing and communications. Additionally, Bashore will manage the launch of Caron’s upcoming medical facility the Keele Center in 2023.


“Kris is a remarkable leader who is always one step ahead,” Brad Sorte, Caron’s President and CEO, said in a statement. “She was integral to the development of our new strategic plan that we are about to embark on. Her understanding of the organization’s clinical excellence, its values-driven mission and its culture of inclusion is exactly what we need to take Caron to the next level.”

Founded in 1957, the Wernersville, Pennsylvania-based company is focused on providing care for patients with substance use disorder. The provider currently operates in Pennsylvania, Floria, Washington D.C., Georgia and New York.

This news comes just weeks after Caron announced the opening of The Fran and Doug Tieman Center for Research, a nonprofit addiction treatment facility with a focus on medical research.


The research center will zero in on various components of substance use disorder including finding genetic markers for an increased addiction risk, relapse prediction and repurposing FDA approved medications to treat other conditions, according to a news release.

“Research done well requires proper funding, precision, patience and diligence,” Dr. Joseph Garbely, the chief medical officer and executive vice president at the Caron Treatment Centers, said in a statement. “By making this investment, we can substantially improve our understanding of relapse, increase treatment options and identify tools and markers to make addiction a significantly more preventable and treatable disease.”

Companies featured in this article: